TY  - JOUR
T1  - Lifestyle and adiponectin level: Four-year follow-up of controlled trials
AU  - Esposito K, Giugliano D
Y1  - 2010/07/26
N1  - 10.1001/archinternmed.2010.246
JO  - Archives of Internal Medicine
SP  - 1270
EP  - 1271
VL  - 170
IS  - 14
N2  - 
The adiponectin adipocyte-secreted adipokine has both insulin-enhancer and anti-inflammatory properties1 and is the most consistent biochemical predictor of type 2 diabetes mellitus. Higher adiponectin levels are consistently associated with a lower risk of type 2 diabetes in 13 prospective studies of diverse populations with a total of 14 598 participants and 2623 incident cases of type 2 diabetes, with a relative risk of 0.72 (95% confidence interval, 0.67-0.78) per 1-log μg/mL increment in adiponectin levels.2 Identification of lifestyle changes able to increase adiponectin circulating levels may help refine the strategy against the current diabetes epidemics.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2010.246
UR  - http://dx.doi.org/10.1001/archinternmed.2010.246
ER  -